As Politicians Argue About China, US Patients Find Cutting-Edge Treatment There
The rapid emergence of the Chinese biotech industry has panicked U.S. politicians, but investors and patients caution that a clampdown on pharmaceutical collaboration could hurt everyone.
We haven't written up this one. KFF Health News has the full story — the link below goes straight to it.